| HOME >> MEDICINE >> TECHNOLOGY |
734,711945,880Long-term investments
2,685,6604,429,140Deferred tax assets
117,181122,872Total assets
$21,380,674$22,290,813Liabilities and Shareholders' EquityCurrent liabilities:Accounts payable
$724,802$593,585Current portion – deferred rent
35,00035,000Income tax payable
7,37817,892Accrued liabilities:Compensation
1,365,2471,576,147Other
419,533316,995Total current liabilities
2,551,9602,539,619Deferred rent – less current portion
32,93242,043Accrued pension liability
491,562474,396Total liabilities
3,076,4543,056,058Total shareholders' equity
18,304,22019,234,755Total liabilities and shareholders' equity
$21,380,674$22,290,813
UROPLASTY, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)Three Months EndedJune 3020122011Cash flows from operating activities:Net loss
$ (1,019,355)$ (1,331,307)Adjustments to reconcile net loss to net cash used in operations:Depreciation and amortization
288,548274,102Loss on disposal of equipment
5995,996Amortization of premium on marketable securities
8,09111,656Share-based consulting expense
1,6231,449Share-based compensation expense
162,435130,352Deferred income taxes
(1,117)(1,462)Deferred rent
(9,111)(8,807)Changes in operating assets and liabilities:Accounts receivable, net
24,32968,193Inventories
(122,672)(35,090)Other current assets
(107,267)(96,533)Accounts payable
137,599(94,797)Accrued liabilities
(106,432)(329,364)Accrued pension liability, net
41,02942,082Net cash used in operating activities
(701,701)(1,363,530)Cash flows from investing activities:Proceeds from maturity of held-to-maturity marketable securities
3,320,0001,500,000Proceeds
'/>"/>
| SOURCE Uroplasty, Inc. Copyright©2012 PR Newswire. All rights reserved |